MCT2D
US$ 23.40
liraglutide and semaglutide market Share Report, 2023-2032 Liraglutide vs Semaglutide: Comparing Weight
Description
Supplied as a lyophilised powder in a sealed laboratory vial
Side effects How to switch.
#GLP1 #WeightLossDrugs #PharmaRegulation #DrugPolicy #IndianPharma #HealthcarePolicy #ObesityTreatment #PharmaIndustry #DrugMarketing #ETPharma #HealthcareNews #LifeSciences
This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide and costs to consumers will triple, from $350 a month to $1,000.
They are no longer even pretending to be about improving health
